Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 928,010	$ 9,246,592
Accounts receivable, net of allowances of $0 and $10,272, respectively	187,682	122,379
Inventory, net	236,110	254,352
Prepaid insurance and services	177,836	384,889
Prepaid clinical expenses	1,726,970	2,310,045
Total current assets	3,256,608	12,318,257
FURNITURE AND EQUIPMENT, NET	19,988	38,332
RIGHT-OF-USE LEASE ASSETS, NET	26,636	890,949
NON-CURRENT PREPAID CLINICAL EXPENSES	1,950,670	0
TOTAL ASSETS	5,253,902	13,247,538
CURRENT LIABILITIES
Current portion of lease liabilities	20,116	1,010,631
Convertible note payable	12,178,000	0
Accounts payable and accrued expenses	6,521,983	7,457,416
Total current liabilities	18,720,099	8,468,047
LONG-TERM LIABILITIES
Lease liabilities, net of current portion	7,143	22,484
Total long-term liabilities	7,143	22,484
Commitments and Contingencies
STOCKHOLDERS' EQUITY
Preferred stock, par value $.0001 per share, 5,000,000 shares authorized, 0 outstanding	0	0
Common stock, par value $.0001 per share, 250,000,000 shares authorized, 28,768,055 and 28,556,072 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	2,877	2,856
Additional paid-in capital	89,537,725	88,610,832
Accumulated deficit	(103,013,942)	(83,856,681)
Total stockholders' equity (deficit)	(13,473,340)	4,757,007
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 5,253,902	$ 13,247,538